The symptomatic benefit (the clinical benefit response) from the second-line chemotherapy in patients with advanced gastric adenocarcinoma
O. SENCAN, A. BUYUKCELIK, B. YALCIN, M.C. BORUBAN, H. AKBULUT, A. DEMIRKAZIK, F.C. SENLER, H. ONUR, F. ICLIVolume:
17
Year:
2008
Language:
english
DOI:
10.1111/j.1365-2354.2007.00798.x
File:
PDF, 68 KB
english, 2008